Cyprium Therapeutics, Inc. — Form D
Cyprium Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-27. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-10-27
- Form: D
- Accession: 0001104659-21-130370
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Minimum investment: $25K
- Investors: 75
- Date of first sale: 2020-07-27
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-418723
Issuer
- Name: Cyprium Therapeutics, Inc.
- CIK: 0001890689
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Phone: 781-652-4500
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Lindsay A Rosenwald | Director | New York, NY |
| Lung Yam | Executive Officer | New York, NY |
More